SEC Form 4 · accession 0001209191-16-096136
Evoke Pharma Inc · EVOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Gonyer
Officer — President and CEO · Director
Period of report
Feb 5, 2016
Accepted (ET)
Feb 5, 2016 · 7:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403708
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $8.67 | Feb 5, 2016 | D | 94,250 | D | — | Dec 1, 2023 | Common Stock | 94,250 | 0 | D |
| Stock Option (Right to Buy)F4,F3 | $6.22 | Feb 5, 2016 | D | 80,000 | D | — | Mar 5, 2025 | Common Stock | 80,000 | 0 | D |
| Stock Option (Right to Buy)F5 | $3.04 | Feb 5, 2016 | A | 70,687 | A | — | Dec 1, 2023 | Common Stock | 70,687 | 70,687 | D |
| Stock Option (Right to Buy)F5 | $3.04 | Feb 5, 2016 | A | 60,000 | A | — | Mar 5, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period following the date of grant (12/2/2013), subject to the reporting person's continued service to the Issuer through each such vesting date.
- F2On February 5, 2016, the Issuer canceled an option granted on December 2, 2013. In exchange for the canceled option, the reporting person received 70,687 options to purchase common stock.
- F3The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2015, subject to the reporting person's continued service to the Issuer through each such vesting date.
- F4On February 5, 2016, the Issuer canceled an option granted on March 6, 2015. In exchange for the canceled option, the reporting person received 60,000 options to purchase common stock.
- F5The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date.